EODData

MEMBERSHIP REGISTER LOG IN

FRA, 24H: Hansa Biopharma AB

17 Aug 2026
LAST:

3.464

CHANGE:
 0.11		OPEN:
3.464		HIGH:
3.464		ASK:
0.000		VOLUME:
0
CHG(%):
2.97		PREV:
3.570		LOW:
3.464		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
17 Aug 263.4643.4643.4643.4640
14 Aug 263.5703.5703.5703.5700
13 Aug 263.6383.6383.6383.6380
12 Aug 263.5843.5843.5843.5840
07 Aug 263.3443.3443.3443.3440
06 Aug 263.0503.0503.0503.0500
05 Aug 262.9522.9522.9522.9520
04 Aug 262.9322.9322.9322.9320
03 Aug 263.0683.0683.0683.0680
31 Jul 263.0423.0423.0423.0420

PROFILE

Name:Hansa Biopharma AB
About:Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Sector:Healthcare
Industry:Biotechnology
Address:ScheelevAegen 22, Lund, Sweden, 223 63
Website:https://www.hansabiopharma.com
ISIN:SE0002148817
LEI:549300LLEO25ZJJ3NT91

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-0.46 
PEG Ratio:0.01 
Price to Sales:1.36 
Price to Book:-1.12 
Profit Margin:0.62 
Operating Margin:-1.84 
Return on Assets:-0.38 
Return on Equity:6.00 
Revenue:222.27M 
Shares:82.73M 
Market Cap:286.56M 

TECHNICAL INDICATORS

MA5:3.521.6%
MA10:3.266.1%
MA20:3.1410.4%
MA50:3.0214.8%
MA100:2.8421.8%
MA200:2.9318.4%
STO9:75.35
STO14:75.35
RSI14:68.93 
WPR14:-24.65
MTM14:0.12
ROC14:0.04 
ATR:0.14 
Week High:3.645.0%
Week Low:3.460.0%
Month High:3.645.0%
Month Low:2.7218.4%
Year High:3.809.7%
Year Low:2.1958.0%
Volatility:45.64